Human CD3 ELISA Standard Curve. Direct ELISA binding curve demonstrating the recognition of Human Anti-Human CD3 (Research Grade Otelixizumab Biosimilar) Monoclonal Antibody to CD3. The target protein was coated onto the microplate well surface, followed by binding of the antibody. A donkey anti-human IgG HRP conjugate was used for detection.
| Clone | Otelixizumab Biosimilar |
|---|---|
| Molecular Weight | 150 kDa |
| Endotoxin | <1EU/mg (<0.001EU/μg)Determined by LAL gel clotting assay |
| Sterility | 0.2 μm filtration |
| Aggregation | <5% Determined by SECP |
| Purity | >95% Determined by SDS-PAGE |
| Production | Purified from cell culture supernatant in an animal-free facility |
|---|---|
| Purification | Protein A or G purification |
| Storage | 2 - 8°C for up to 4 weeks and -80°C for long term storage (Avoid repeated freezing and thawing) |
| Isotype | Human IgG1 kappa |
|---|---|
| Recommended Dilution Buffer | 1×PBS pH 7.0 |
* For research use only. Not for therapeutic or diagnostic purposes.
m10_FC_01.jpg?t=1712741424)
i_FC_01.jpg?t=1718275406)
